JP MORGAN/CALL/ABBOTT LABORATORIES/160/0.1/16.01.26 Share Price

Warrant

DE000JK50Z80

Delayed Börse Stuttgart 07:59:13 29/05/2024 BST
0.092 EUR -16.36% Intraday chart for JP MORGAN/CALL/ABBOTT LABORATORIES/160/0.1/16.01.26
1 month-38.89%
Date Price Change
29/05/24 0.092 -16.36%
28/05/24 0.11 0.00%
27/05/24 0.11 -8.33%
24/05/24 0.12 -7.69%
23/05/24 0.13 +18.18%

Delayed Quote Börse Stuttgart

Last update May 29, 2024 at 07:59 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer J.P. Morgan
WKN JK50Z8
ISINDE000JK50Z80
Date issued 04/04/2024
Strike 160 $
Maturity 16/01/2026 (598 Days)
Parity 10 : 1
Emission price 0.23
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.27
Lowest since issue 0.092
Spread 0.058
Spread %38.67%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
102 USD
Average target price
125.7 USD
Spread / Average Target
+23.29%
Consensus